Old Pharmaceutical Factory:    

Le's Tongren Sanmenxia Pharmaceutical Co., Ltd. is a modernized traditional Chinese medicine pharmaceutical enterprise built according to GMP standards, and is a wholly-owned subsidiary of Le's Tongren Pharmaceutical Technology Group Co.

The company has 298 employees, including 79 professional and technical personnel in pharmacy. The company covers an area of 86.7 acres, with a building area of 16,800 square meters and a greening area of 30,000 square meters. The layout of the building is reasonable and meets the requirements of greening, purification, beautification and brightening.

The company now has four dosage forms of tablets, pills (honey pills, water pills), bulk dosage, granules (including pre-treatment and extraction of traditional Chinese medicine), with 50 varieties. The annual production capacity is 4.5 billion tablets, 30 million bags of pills, 50 million bags of dispersions and 50 million bags of granules.

The company's main products include 50 varieties, including Lipid Reducing Tablets, Lian Pu Shuang Qing Tablets, Huanglian Shang Qing Tablets, Puerariae Radix Scutellariae Lian Granules, Astragalus Pseudostellariae Granules, Shuji Xuanzhi Blood Granules, Shuji Xuanzhi Blood Granules, Stomach Enhancement Tablets, Kidney Nourishing Tablets, Infant's Spleen Strengthening Granules and so on, among which there are two national protected varieties of traditional Chinese medicines: Lipid Reducing Tablets and Lian Pu Shuang Qing Tablets. Pueraria Mirifica Granules is a new drug of the fourth category of the state, and Astragalus Panax Quinquefolius Granules is a new drug of the third category of the state, and the sales of the products basically cover the whole country.

New Pharmaceuticals:

Le's Tongren Pharmaceutical Science and Technology Group Co. Ltd. started the off-site expansion of the pharmaceutical factory in 2016. The total investment of the off-site expansion project is 1.08 billion yuan, covering a total area of 185 acres, with a total construction area of 85,000 square meters, including 67,000 square meters of production workshops, 4,800 square meters of exhibition halls, 9,000 square meters of research and development centers and laboratories, and 3,500 square meters of warehouses and auxiliary facilities. The company is designed to produce 18 billion tablets of traditional Chinese medicine, 400 million pills of traditional Chinese medicine, 54 tons of water pills, 130 tons of dispersions, 13.88 million bags of granules, and 6,000 tons of traditional Chinese medicine tablets (more than 400 varieties) annually.

The company now has 52 drug approval numbers for four dosage forms. Especially, the advantageous products such as Qi San Qi Blood Granules, Ge Gen Scutellariae Granules and Lipid Reducing Tablets have strong competitiveness in the market. Astragalus Panax Ginseng Blood Granules is a national exclusive variety, while Ge Ge Gen Scutellariae Granules and Lipid Reducing Spirit Tablets have fewer manufacturers and have a strong competitive advantage in the market. At present, the company has launched a key product - Ten Major Pills, which is made of selected local herbs and ancient concoctions, which greatly enhances the efficacy of the product.